Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 15.95
-0.10 (-0.62%)
Nov 3, 2025, 1:38 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 9.33 billion as of October 31, 2025. Its market cap has decreased by -28.24% in one year.
Market Cap
9.33B
Enterprise Value
4.49B
Revenue
301.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
15.95
Market Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 9.33B, a decrease of -59.29%. That is a compound annual growth rate of -33.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 9.33B | -6.46% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |